US Stock MarketDetailed Quotes

Ionis Pharmaceuticals (IONS)

Watchlist
  • 75.830
  • +0.450+0.60%
Close May 12 16:00 ET
  • 75.657
  • -0.173-0.23%
Post 16:51 ET
12.53BMarket Cap-37.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ionis Pharmaceuticals (IONS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
86.98%246.09M
33.83%943.71M
-10.26%203.33M
17.12%156.72M
100.69%452.05M
10.14%131.61M
-10.48%705.14M
-30.18%226.58M
-7.21%133.81M
19.55%225.25M
Operating revenue
86.98%246.09M
33.83%943.71M
-10.26%203.33M
17.12%156.72M
100.69%452.05M
10.14%131.61M
-10.48%705.14M
-30.18%226.58M
-7.21%133.81M
19.55%225.25M
Cost of revenue
100.00%3M
41.85%15.91M
107.75%7.96M
118.30%2.34M
-0.31%4.15M
-31.82%1.5M
22.80%11.22M
25.08%3.83M
-51.12%1.07M
64.13%4.16M
Gross profit
86.83%243.09M
33.70%927.8M
-12.29%195.37M
16.30%154.38M
102.59%447.9M
10.93%130.11M
-10.87%693.92M
-30.70%222.75M
-6.53%132.74M
18.94%221.09M
Operating expense
30.14%360.57M
12.02%1.31B
22.86%409.85M
11.80%314.55M
7.28%308.06M
3.84%277.06M
3.25%1.17B
1.84%333.59M
-1.39%281.36M
4.02%287.16M
Selling and administrative expenses
97.12%150.4M
47.25%393.9M
47.79%130.2M
57.14%96.8M
39.17%90.6M
45.06%76.3M
14.99%267.5M
24.05%88.1M
-12.00%61.6M
41.09%65.1M
-General and administrative expense
97.12%150.4M
47.25%393.9M
47.79%130.2M
57.14%96.8M
39.17%90.6M
45.06%76.3M
15.00%267.5M
24.08%88.1M
-12.00%61.6M
--65.1M
Research and development costs
4.69%210.17M
1.56%915.62M
13.91%279.65M
-0.91%217.75M
-2.07%217.46M
-6.28%200.76M
0.21%901.53M
-4.31%245.49M
2.06%219.76M
-3.42%222.06M
Operating profit
20.05%-117.48M
19.66%-381.72M
-93.49%-214.47M
-7.77%-160.17M
311.63%139.84M
1.72%-146.95M
-34.31%-475.11M
-1,707.93%-110.84M
-3.70%-148.62M
26.74%-66.08M
Net non-operating interest income expense
1.68%-22.54M
-0.14%-90.58M
0.48%-22.76M
2.56%-22.15M
0.17%-22.75M
-3.44%-22.92M
-11.05%-90.46M
-2.05%-22.87M
-3.43%-22.73M
-14.24%-22.79M
Non-operating interest expense
-5.06%20.34M
-0.09%84.28M
-0.98%21.06M
-3.21%20.55M
-6.75%21.25M
4.20%21.42M
3.56%84.36M
-20.37%21.27M
4.19%21.23M
14.24%22.79M
Total other finance cost
46.67%2.2M
3.28%6.3M
6.25%1.7M
6.67%1.6M
--1.5M
-6.25%1.5M
3.39%6.1M
0.00%1.6M
-6.25%1.5M
----
Other net income (expense)
107.29%47.61M
-12.17%92.63M
-65.35%9.23M
98.00%53.95M
-71.44%6.48M
-20.51%22.97M
4.19%105.46M
3.42%26.64M
11.50%27.25M
-30.64%22.68M
Gain on sale of security
113.60%48.07M
3.70%107.99M
-3.13%25.52M
97.70%53.59M
-71.11%6.38M
-21.37%22.5M
19.52%104.13M
3.20%26.34M
23.26%27.11M
2.58%22.07M
Other non- operating income (expenses)
-198.06%-456K
-1,253.87%-15.36M
-5,493.05%-16.29M
155.63%363K
-83.28%102K
67.87%465K
-90.56%1.33M
26.89%302K
-94.20%142K
-94.55%610K
Income before tax
37.13%-92.31M
17.49%-379.6M
-112.93%-227.92M
10.90%-128.39M
286.60%123.53M
-2.87%-146.82M
-37.76%-460.07M
-3,768.41%-107.04M
-2.34%-144.1M
14.52%-66.2M
Income tax
87.93%218K
128.94%1.79M
154.94%1.48M
105.88%213K
-131.25%-20K
54.67%116K
-119.09%-6.17M
-141.41%-2.69M
-154.85%-3.62M
-99.18%64K
Net income
37.03%-92.53M
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
Net income continuous Operations
37.03%-92.53M
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
Minority interest income
Net income attributable to the parent company
37.03%-92.53M
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.03%-92.53M
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
Basic earnings per share
39.78%-0.56
21.71%-2.38
-113.64%-1.41
15.79%-0.8
273.33%0.78
5.10%-0.93
-18.75%-3.04
-1,000.00%-0.66
7.77%-0.95
25.00%-0.45
Diluted earnings per share
39.78%-0.56
21.71%-2.38
-113.64%-1.41
15.79%-0.8
255.56%0.7
5.10%-0.93
-18.75%-3.04
-1,000.00%-0.66
7.77%-0.95
25.00%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 86.98%246.09M33.83%943.71M-10.26%203.33M17.12%156.72M100.69%452.05M10.14%131.61M-10.48%705.14M-30.18%226.58M-7.21%133.81M19.55%225.25M
Operating revenue 86.98%246.09M33.83%943.71M-10.26%203.33M17.12%156.72M100.69%452.05M10.14%131.61M-10.48%705.14M-30.18%226.58M-7.21%133.81M19.55%225.25M
Cost of revenue 100.00%3M41.85%15.91M107.75%7.96M118.30%2.34M-0.31%4.15M-31.82%1.5M22.80%11.22M25.08%3.83M-51.12%1.07M64.13%4.16M
Gross profit 86.83%243.09M33.70%927.8M-12.29%195.37M16.30%154.38M102.59%447.9M10.93%130.11M-10.87%693.92M-30.70%222.75M-6.53%132.74M18.94%221.09M
Operating expense 30.14%360.57M12.02%1.31B22.86%409.85M11.80%314.55M7.28%308.06M3.84%277.06M3.25%1.17B1.84%333.59M-1.39%281.36M4.02%287.16M
Selling and administrative expenses 97.12%150.4M47.25%393.9M47.79%130.2M57.14%96.8M39.17%90.6M45.06%76.3M14.99%267.5M24.05%88.1M-12.00%61.6M41.09%65.1M
-General and administrative expense 97.12%150.4M47.25%393.9M47.79%130.2M57.14%96.8M39.17%90.6M45.06%76.3M15.00%267.5M24.08%88.1M-12.00%61.6M--65.1M
Research and development costs 4.69%210.17M1.56%915.62M13.91%279.65M-0.91%217.75M-2.07%217.46M-6.28%200.76M0.21%901.53M-4.31%245.49M2.06%219.76M-3.42%222.06M
Operating profit 20.05%-117.48M19.66%-381.72M-93.49%-214.47M-7.77%-160.17M311.63%139.84M1.72%-146.95M-34.31%-475.11M-1,707.93%-110.84M-3.70%-148.62M26.74%-66.08M
Net non-operating interest income expense 1.68%-22.54M-0.14%-90.58M0.48%-22.76M2.56%-22.15M0.17%-22.75M-3.44%-22.92M-11.05%-90.46M-2.05%-22.87M-3.43%-22.73M-14.24%-22.79M
Non-operating interest expense -5.06%20.34M-0.09%84.28M-0.98%21.06M-3.21%20.55M-6.75%21.25M4.20%21.42M3.56%84.36M-20.37%21.27M4.19%21.23M14.24%22.79M
Total other finance cost 46.67%2.2M3.28%6.3M6.25%1.7M6.67%1.6M--1.5M-6.25%1.5M3.39%6.1M0.00%1.6M-6.25%1.5M----
Other net income (expense) 107.29%47.61M-12.17%92.63M-65.35%9.23M98.00%53.95M-71.44%6.48M-20.51%22.97M4.19%105.46M3.42%26.64M11.50%27.25M-30.64%22.68M
Gain on sale of security 113.60%48.07M3.70%107.99M-3.13%25.52M97.70%53.59M-71.11%6.38M-21.37%22.5M19.52%104.13M3.20%26.34M23.26%27.11M2.58%22.07M
Other non- operating income (expenses) -198.06%-456K-1,253.87%-15.36M-5,493.05%-16.29M155.63%363K-83.28%102K67.87%465K-90.56%1.33M26.89%302K-94.20%142K-94.55%610K
Income before tax 37.13%-92.31M17.49%-379.6M-112.93%-227.92M10.90%-128.39M286.60%123.53M-2.87%-146.82M-37.76%-460.07M-3,768.41%-107.04M-2.34%-144.1M14.52%-66.2M
Income tax 87.93%218K128.94%1.79M154.94%1.48M105.88%213K-131.25%-20K54.67%116K-119.09%-6.17M-141.41%-2.69M-154.85%-3.62M-99.18%64K
Net income 37.03%-92.53M15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M
Net income continuous Operations 37.03%-92.53M15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M
Minority interest income
Net income attributable to the parent company 37.03%-92.53M15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.03%-92.53M15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M
Basic earnings per share 39.78%-0.5621.71%-2.38-113.64%-1.4115.79%-0.8273.33%0.785.10%-0.93-18.75%-3.04-1,000.00%-0.667.77%-0.9525.00%-0.45
Diluted earnings per share 39.78%-0.5621.71%-2.38-113.64%-1.4115.79%-0.8255.56%0.75.10%-0.93-18.75%-3.04-1,000.00%-0.667.77%-0.9525.00%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -